药物耐药性腹膜炎的腹腔内胆固醇素:最终的治疗选择?
Mohammed Nadeem1, Subhas Konar2, T Vidhya1
1Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bengaluru, Karnataka, 560029, India.
Neurosurgical review
|February 21, 2026
概括
静脉内胆固醇结合静脉内疗法有效治疗多药耐药腹膜炎. 较长的治疗时间 (≥10天) 显著改善了感染控制,并降低了神经外科患者的死亡率.
科学领域:
- 神经外科 神经外科
- 传染性疾病 传染性疾病
- 药理学 药理学 是一个学科.
背景情况:
- 多抗药性 (MDR) 腹腔炎在神经外科手术后构成重大威胁.
- 对MDR腹腔炎的治疗选择有限,需要新的治疗策略.
研究的目的:
- 为了评估静脉内肠道 (IVT) 胆固醇素与MDR心室炎的静脉内治疗相结合的疗效和安全性.
- 在大型单中心系列中确定最佳的治疗持续时间和结果.
主要方法:
- 在2023年1月至2024年12月期间治疗的46名培养证明的MDR心室炎患者的回顾性分析.
- 通过外部心室排水 (EVD) 给药的IVT胆固醇素 (10 mg) 持续时间可变.
- 患者接受≥10天的联合治疗与较短的疗程或单独静脉注射胆固醇素之间的结局的比较.
主要成果:
- 在63.6%的病例中实现了感染控制,中位数CSF绝育时间为7.5天.
- 接受≥10天IVT加静脉胆固醇治疗的患者的感染控制率显著提高 (94%vs. 37%) 和死亡率降低 (45%vs. 75%).
- 最常见的病原体是Acinetobacter baumannii (50%);8.7%的不良反应仅限于急性损伤,没有神经毒性.
结论:
- 静脉输入胆固醇是一种安全有效的MDR心室炎的辅助疗法,特别是当服用≥10天时.
- 这种治疗策略显著改善了感染控制,并可能减少与感染有关的死亡率.
- 应考虑使用IVT胆固醇治疗MDR细菌阴性心室炎,为标准化方案需要进行前性研究.
相关概念视频
01:18Endocarditis III: Medical Management
277
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
277
01:29Endocarditis IV: Nursing Management
423
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
423
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
486
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
486
01:17Urinary Tract Infection IV: Nursing Management
524
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
524
01:28Pneumonia IV: Management
852
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
852
01:29Drug Delivery: Parenteral Route
1.9K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.9K